Indeed, siRNA-mediated knockdown of c-MYC induced a significant upregulation of miR-22 levels in AMO-1 MM cells, thus providing a possible explanation of miR-22 downregulation in these subgroups of MM patients (Supplementary Fig. 3d). The gene discussed is MYC; the disease is Miyoshi myopathy.